The treatment of cutaneous melanoma (CM) and many other tumors has been revolutionized by new therapeutic options that are constantly improving the overall survival. However, the mucosal melanoma remains (MM) a rare tumor disease with a poor clinical outcome. MM is a neuroectodermal tumor arising from melanocytes. Precursors of melanocytes arise from the neural crest, from where they migrate to their final destination through embryonic mesenchyme, along specific pathways [1].
https://ift.tt/2LR6Hp0
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου